chr19-12526492-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_144976.4(ZNF564):āc.1616A>Cā(p.Lys539Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,454,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_144976.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF564 | NM_144976.4 | c.1616A>C | p.Lys539Thr | missense_variant | 4/4 | ENST00000339282.12 | NP_659413.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF564 | ENST00000339282.12 | c.1616A>C | p.Lys539Thr | missense_variant | 4/4 | 1 | NM_144976.4 | ENSP00000340004.6 | ||
ENSG00000196826 | ENST00000428311.1 | c.3+24838A>C | intron_variant | 2 | ENSP00000404127.1 | |||||
ENSG00000269693 | ENST00000593682.1 | n.*4594A>C | non_coding_transcript_exon_variant | 4/4 | 1 | ENSP00000473043.1 | ||||
ENSG00000269693 | ENST00000593682.1 | n.*4594A>C | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000473043.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000821 AC: 2AN: 243720Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132356
GnomAD4 exome AF: 0.0000131 AC: 19AN: 1454870Hom.: 0 Cov.: 31 AF XY: 0.0000152 AC XY: 11AN XY: 723604
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 07, 2024 | The c.1616A>C (p.K539T) alteration is located in exon 4 (coding exon 4) of the ZNF564 gene. This alteration results from a A to C substitution at nucleotide position 1616, causing the lysine (K) at amino acid position 539 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at